Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barri J Fessler

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
The Clinical Journal of Pain|January 9, 2015
A Cross-sectional Examination of Vitamin D, Obesity, and Measures of Pain and Function in Middle-aged and Older Adults With Knee OsteoarthritisToni L Glover, Burel R Goodin, Christopher D King, et al.
American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMarco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, et al.
Arthritis and Rheumatism|September 29, 2011
Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitisPaul A Monach, Gunnar Tomasson, Ulrich Specks, et al.
Arthritis and Rheumatism|February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung StudyDinesh Khanna, Philip J Clements, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|September 15, 2012
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitisPaul A Monach, Roscoe L Warner, Gunnar Tomasson, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Seminars in Arthritis and Rheumatism|January 13, 2015
Antinuclear antibody-negative systemic sclerosisGloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
Plos One|January 3, 2018
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populationsOlga Y Gorlova, Yafang Li, Ivan Gorlov, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The Clinical Journal of Pain|January 9, 2015
A Cross-sectional Examination of Vitamin D, Obesity, and Measures of Pain and Function in Middle-aged and Older Adults With Knee OsteoarthritisToni L Glover, Burel R Goodin, Christopher D King, et al.
American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMarco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, et al.
Arthritis and Rheumatism|September 29, 2011
Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitisPaul A Monach, Gunnar Tomasson, Ulrich Specks, et al.
Arthritis and Rheumatism|February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung StudyDinesh Khanna, Philip J Clements, Daniel E Furst, et al.
Annals of the Rheumatic Diseases|September 15, 2012
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitisPaul A Monach, Roscoe L Warner, Gunnar Tomasson, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Seminars in Arthritis and Rheumatism|January 13, 2015
Antinuclear antibody-negative systemic sclerosisGloria A Salazar, Shervin Assassi, Fredrick Wigley, et al.
Plos One|January 3, 2018
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populationsOlga Y Gorlova, Yafang Li, Ivan Gorlov, et al.
Pageof 6